Navigation Links
Onyx Pharmaceuticals Announces Data Presentations Highlighting Carfilzomib at 53rd American Society of Hematology Annual Meeting
Date:11/7/2011

oster I
  • Abstract #1877

  • A Phase 1b/2 Study of Prolonged Infusion Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma: Updated Efficacy and Tolerability from the Completed 20/56 mg/m2 Expansion Cohort of PX-171-007

    • Dr. Kyriakos Papadopoulos, South Texas Accelerated Research Therapeutics
    • Sunday, December 11, 2011, 6:00 – 8:00 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: Poster II
    • Abstract #2930

    Phase 2 Study of Carfilzomib Combined with Other Anti-Myeloma Agents in Relapsed-Refractory Multiple Myeloma - Updates on the UARK Compassionate Use Protocol

    • Dr. Saad Usmani, University of Arkansas for Medical Sciences
    • Sunday, December 11, 2011, 6:00 – 8:00 p.m., Hall GH
    • Poster session: Myeloma - Therapy, excluding Transplantation: Poster II
    • Abstract #2947

    The Speed of Response to Single-Agent Carfilzomib in Patients with Relapsed and/or Refractory Multiple Myeloma: An Exploratory Analysis of Results from Two Multicenter Phase 2 Clinical Trials

    • Dr. Michael Wang, The University of Texas MD Anderson Cancer Center
    • Monday, December 12, 2011, 6:00 – 8:00 p.m., Hall GH
    • Poster session: Myeloma – Therapy, excluding Transplantation: Poster III
    • Abstract #3969

    Carfilzomib Development Program
    Carfilzomib is being studied in several clinical trials either as a single-agent or in combination with other therapies, including:

    • A Phase 3 clinical trial, known as the ASPIRE trial, is evaluating the combination of lenalidomide and low dose dexamethasone with or without carfilzomib in patients with relapsed multiple myeloma who have received one to three prior therapies. The com
      '/>"/>

    SOURCE Onyx Pharmaceuticals, Inc.
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6

    Related medicine technology :

    1. Anadys Pharmaceuticals Reports Third Quarter 2011 Financial Results and Highlights
    2. Planet Biopharmaceuticals, Inc. Divests Assets of Allergy Control Products, Inc.
    3. Inovio Pharmaceuticals Reports 2011 Third Quarter Financial Results
    4. Savient Pharmaceuticals Announces New Data Surrounding KRYSTEXXA® and the Impact of Refractory Chronic Gout at the American College of Rheumatology Meeting
    5. Vanda Pharmaceuticals Reports Third Quarter 2011 Results
    6. Quanticel Pharmaceuticals Enters Into Strategic Cancer Drug Discovery Collaboration With Celgene Corporation
    7. Cadence Pharmaceuticals Reports Third Quarter 2011 Financial Results
    8. Savient Pharmaceuticals Reports Third Quarter 2011 Financial Results
    9. Keryx Biopharmaceuticals, Inc. Announces Third Quarter 2011 Financial Results
    10. Onyx Pharmaceuticals Reports Third Quarter 2011 Financial Results
    11. Idenix Pharmaceuticals Reports Third Quarter and Nine Month 2011 Financial Results and Provides Pipeline Update
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:10/25/2014)... 24, 2014  America,s future engineers will connect ... at the  Medical Design and Manufacturing (MD&M) Minneapolis ... at the Minneapolis ... built robots from the "For Inspiration and Recognition ... and mentors will offer information to those curious ...
    (Date:10/25/2014)... 2014  The National Association of Drug Diversion ... by Kentucky,s real-time, stop-sale ... National Precursor Log Exchange (NPLEx) system automatically blocks ... and helps flag meth offenders for law enforcement. ... NPLEx "watch lists" that notify them via email ...
    (Date:10/25/2014)... Oct. 24, 2014 In conjunction with DURECT ... financial results press release, you are invited to listen ... over the internet on Monday, November 3, 2014 at ... A live audio webcast of the presentation will ... and clicking "Investor Relations."  If you are unable ...
    Breaking Medicine Technology:Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 2Local robotics teams compete - a "FIRST" at next week's MD&M Minneapolis- October 29-30th at the Minneapolis Convention Center 3Kentucky's NPLEx Technology Making Significant Progress 2DURECT Corporation Invites You to Join its Third Quarter 2014 Earnings Conference Call 2
    (Date:10/25/2014)... Mesothelioma researchers are reporting extended survival in ... after his combination drug therapy became too toxic. ... posted on the Surviving Mesothelioma website. , A ... Japan suggests that “maintenance therapy” with pemetrexed may be ... tolerate higher doses of cisplatin. , “Although the ...
    (Date:10/25/2014)... HealthDay Reporter FRIDAY, Oct. 24, 2014 ... -- herpes simplex -- might increase the risk of Alzheimer,s ... being a carrier of certain antibodies to the virus can ... "The identification of a treatable cause [herpes simplex] of ... researcher Dr. Hugo Lovheim, an associate professor in the department ...
    (Date:10/25/2014)... News) -- A large influx of international aid is ... tens of thousands of deaths from the widening Ebola ... Using a specially designed mathematical model, the researchers ... just one densely populated county of hard-hit Liberia -- ... The researchers said that if international aid isn,t ...
    (Date:10/25/2014)... (HealthDay News) -- October,s shorter, darker days can trigger ... according to an expert. People affected by ... tired, lack motivation and even have trouble getting out ... suicide, said Dr. Angelos Halaris, a professor in the ... Chicago Stitch School of Medicine. "Seasonal affective disorder ...
    (Date:10/22/2014)... 22, 2014 On October 22, CBS ... featuring skin diseases both fictional and real. The ... nonprofit organization committed to advocacy and philanthropy in the ... take the opportunity to impart truth and clarity about ... There are many misconceptions about Morgellons Disease ...
    Breaking Medicine News(10 mins):Health News:New Report Illustrates Extended Mesothelioma Survival with “Maintenance Therapy”, According to Surviving Mesothelioma 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 2Health News:Studies Link Cold Sore Virus to Alzheimer's Risk 3Health News:Experts Predict 'Catastrophic' Ebola Epidemic in West Africa if Aid Delayed 2Health News:Dark Days Here for Folks With Seasonal Depression 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 2Health News:CBS’ Criminal Minds takes aim at skin disease with Morgellons in the Mix 3
    ... due to use of drugs in northeastern states, Minister ... effective monitoring // and reporting systems in the region ... establish effective drug use monitoring and reporting systems for ... releasing a monograph on the drug use in the ...
    ... have insurance in the U.S. This shows an increase in ... These individuals between the ages of 19 and 29 are the ... and Rite of Passage neither can figure the reason for no ... not insured at double the rate of adults between 30 – ...
    ... hospital here, who have been abstaining from duty for ... to introduce reservation in higher education institutions, today went ... whose stir has disrupted medical services in the Swaroop ... hunger strike which they have vowed to continue unless ...
    ... is usually used to treat insomnia. ,The effects ... of six months by South African researchers//. Neurological rehabilitation experts ... open, awake but unaware of the surroundings, no interaction and ... state. ,Zolpidem was given to the patients ...
    ... of a woman suffering from domestic violence getting in ... department about the topic. This approach however does not ... reveals a study, published in Archives of Internal Medicine, ... issues prevents many physicians from identifying victims of domestic ...
    ... U.S. have given an approval for the drug Remicade ... which is a chronic// and debilitating condition. ... that causes diarrhea, fever, abdominal pain, weight loss and, ... it can involve any area of the gastrointestinal tract ...
    Cached Medicine News:Health News:No Insurance For Young Adults In U.S. 2Health News:No Insurance For Young Adults In U.S. 3Health News:Discussion On Domestic Violence Increased By Computer Based Screening 2Health News:Discussion On Domestic Violence Increased By Computer Based Screening 3Health News:Arthritic Drug Approved For Use In Children With Crohn’s Diseas 2
    ... Leica M844 F40 with its new stand F19 ... allow on the one hand to homogenously move ... operate with a solid and stable microscope. The ... Chrome optics, stands on the same small footprint ...
    ... 2000 assays are designed ... IMMULITE 2000, a high-throughput, ... analyzer. IMMULITE 2000 offers ... and a rapidly expanding ...
    ... Detection Of Serum C-Peptide ... Measurement:, Evaluating patients ... Assisting in the classification ... Differentiating insulin dependent patients ...
    Inquire...
    Medicine Products: